1. HBW Insight
  2. >>Beauty
  3. >>Business
  4. >>Deals

L’Oreal Picks Up CeraVe Skin Care Via $1.3bn Deal With Valeant

The CeraVe, AcneFree and Ambi skin-care lines will change hands from Valeant Pharmaceuticals to L’Oreal under a deal announced Jan. 10, beefing up the latter’s dermatologist-aligned Active Cosmetics division.

L’Oreal S.A. will add the CeraVe skin-care brand and two others to its dermocosmetics division under a $1.3bn acquisition agreement with Valeant Pharmaceuticals International, Inc.,announced Jan. 10.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business